Jennifer L. Lund, PhD

About

Jennifer Lund, MSPH, PhD, FISPE is Associate Professor of Epidemiology and the Director of Data Strategy and Education with the UNC Lineberger’s Cancer Information and Population Health Resource (CIPHR). Dr. Lund conducts pharmacoepidemiologic and health services research with applications to older adult populations and those diagnosed with cancer. The overall objective of her work is to generate robust evidence on the uses, benefits, and harms of medical treatments that will improve decisions made by policymakers, providers, and patients and their families. Dr. Lund’s research program draws upon clinical trials, large healthcare databases, and advanced epidemiologic methods to evaluate: (1) the quality of care received, (2) the effectiveness and safety of treatment options, and (3) the role of polypharmacy, multimorbidity, and frailty in treatment selection, adherence, and outcomes. She serves on the International Society for Pharmacoepidemiology (ISPE) Board of Directors and is an Associate Editor for Pharmacoepidemiology and Drug Safety, as well as an Editorial Board member for Epidemiology and the Journal of Geriatric Oncology.  

Jennifer Lund in the Gillings News

Honors and Awards

Designated a Fellow of the International Society for Pharmacoepidemiology (FISPE)
2021, International Society for Pharmacoepidemiology

Young Investigator Award Finalist
2019, International Society for Geriatric Oncology

Gordon H. DeFriese Career Development in Aging Research Award
2015, Institute on Aging, University of North Carolina at Chapel Hill

Teaching Interests

This course teaches students how to use administrative healthcare utilization data for epidemiologic studies.

Representative Courses

EPID 766: Epidemiologic Research Using Healthcare Databases | Syllabus

Research Activities

Health services research
Pharmacoepidemiology
Comparative effectiveness and safety research
Geriatric oncology research

Service Activities

Member, PhD Admissions Committee, Department of Epidemiology (2019-present)

Member, Graduate Studies Committee, Department of Epidemiology (2014-2018)

Key Publications

Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model. Lund JL, Duberstein PR, Loh KP, Gilmore N, Plumb S, Lei L, Keil AP, Islam JY, Hanson LC, Giguere JK, Vogel VG, Burnette BL, Mohile SG Journal of Geriatric Oncology (In-Press).

Effects of Anticholinergic and Sedative Medication Use on Fractures: A Self-Controlled Design Study. . Shmuel S, Pate V, Pepin MJ, Bailey JC, Golightly YM, Hanson LC, Stürmer T, Naumann RB, Gnjidic D, Lund JL.  Journal of the American Geriatrics Society (In-Press)..

Introducing Longitudinal Cumulative Dose to Describe Chemotherapy Patterns Over Time: Case Study of a Colon Cancer Trial. . Webster-Clark MA, Keil AP, Sanoff HK, Sturmer T, Westreich D, Lund JL. (1970). International Journal of Cancer, 149(2), 394-402.

Adherence to Endocrine Therapy Including Ovarian Suppression: A Large Observational Cohort Study of US Women with Early Breast Cancer. Cancer. . Reeder-Hayes KE, Mayer SE, Lund JL.  (1970). Cancer, 127(8), 1220-1227.

Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study. Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Bhaskaran K, Lund JL (co-senior authors) (2021). Journal of National Comprehensive Cancer Network.

Effectiveness of adjuvant FOLFOX vs 5FU/LV in adults over age 65 with stage II and III colon cancer using a novel hybrid approach. Lund JL, Webster-Clark MA, Hinton SP, Shmuel S, Stürmer T, Sanoff HK. (2020). Pharmacoepidemiology and Drug Safety, 29(12), 1579-1587.

Validation of a 5-Year Mortality Prediction Model among U.S. Medicare Beneficiaries. . Ross RK, Kuo TM, Webster-Clark M, Lewis CL, Kistler CE, Jonsson Funk M, Lund JL. (2020). Journal of the American Geriatrics Society, 68(12), 2898-2902.

Education